RELIANCE GLO HL (00723) is expected to achieve other income from listed securities investments of approximately HK$61.6 million in the fiscal year 2026, representing a year-on-year increase of approximately 16.74 times.

date
17:38 09/04/2026
avatar
GMT Eight
Sinopharm Tech Holdings Limited (00723) announced that it is expected to generate approximately HK$61.6 million in other income from listed securities investments, representing a year-on-year increase of about 16.74 times. It is expected to have a significant impact on the annual performance for the year ending March 31, 2026 compared to the same period last year.
RELIANCE GLO HL (00723) announced that the group is expected to generate approximately 61.6 million Hong Kong dollars in other income from listed securities investments, representing a year-on-year increase of about 16.74 times. It is expected that this will have a significant impact on the full-year performance for the year ending March 31, 2026 compared to the same period last year. This income mainly includes a net profit of approximately 12.8 million Hong Kong dollars from the sale of financial assets measured at fair value through profit or loss, as well as a net fair value gain of approximately 48.8 million Hong Kong dollars on financial assets measured at fair value through profit or loss. Both are influenced favorably by the recovery of the Hong Kong stock market in the 2026 fiscal year.